Subscribe
Israel-Hamas Conflict
US Politics
Hurricanes
Republican Party
Donald Trump
US Presidential Election
Election Day
Fox News
US Economy
Kamala Harris
US Crime
Halloween
NFL
Published

Ozempic may reduce the risk of dementia, according to a new study

Summary by CNN Brasil
New research from Oxford University shows that semaglutide-based medications - such as Ozempic and Wegovy, both from Novo Nordisk pharmaceutical company - are associated with a lower risk of dementia and lower nicotine dependence. The study was published on July 10th in the scientific journal eClinicalMedicine. The researchers wanted to understand if semaglutide diabetes type 2 medications could negatively affect neurological and psychiatric hea…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

DementiaDementia
OzempicOzempic
Oxford UniversityOxford University
BrazilBrazil

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal